Quick Answer
Dare Bioscience, Inc. reported Research And Development Expense of $5.52 million for the year ending 2025.
- Dare Bioscience, Inc. showed a decrease of -61.4% in Research And Development Expense from 2024 to 2025.
- This data is from Dare Bioscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), Dare Bioscience, Inc.'s Research And Development Expense has declined by 65.1%.
- Historical annual values: Fiscal year 2025: $5.52 million | Fiscal year 2024: $14.31 million | Fiscal year 2023: $21.54 million | Fiscal year 2022: $30.04 million | Fiscal year 2021: $30.62 million | Fiscal year 2020: $20.77 million | Fiscal year 2019: $8.55 million | Fiscal year 2018: $6.41 million | Fiscal year 2017: $984.7 thousand | Fiscal year 2016: $72.7 thousand | Fiscal year 2015: $25.95 million | Fiscal year 2014: $11.77 million | Fiscal year 2013: $9.70 million | Fiscal year 2012: $15.81 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: